pharmacor cefuroxime cefuroxime 500mg film coated tablet blister pack
pharmacor pty ltd - cefuroxime axetil, quantity: 601.43 mg - tablet, film coated - excipient ingredients: crospovidone; calcium stearate; purified water; colloidal anhydrous silica; calcium carbonate; microcrystalline cellulose; sodium lauryl sulfate; croscarmellose sodium; titanium dioxide; hypromellose; propylene glycol; brilliant blue fcf aluminium lake - cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis. acute exacerbations of chronic bronchitis, or acute bronchitis. skin and skin structure infections for example, furunculosis, pyoderma and impetigo. acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.
al-cefuroxime cefuroxime 500mg film coated tablet blister pack
pharmacor pty ltd - cefuroxime axetil, quantity: 601.43 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; crospovidone; calcium stearate; microcrystalline cellulose; sodium lauryl sulfate; purified water; calcium carbonate; croscarmellose sodium; titanium dioxide; hypromellose; propylene glycol; brilliant blue fcf aluminium lake - cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis. acute exacerbations of chronic bronchitis, or acute bronchitis. skin and skin structure infections for example, furunculosis, pyoderma and impetigo. acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.
nesina met 12.5/500; 12.5 mg alogliptin (as benzoate) / 500 mg metformin hydrochloride film-coated tablets blister pack
takeda pharmaceuticals australia pty ltd - metformin hydrochloride, quantity: 500 mg; alogliptin benzoate, quantity: 17 mg (equivalent: alogliptin, qty 12.5 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; mannitol; titanium dioxide; magnesium stearate; iron oxide yellow; purified talc; crospovidone; povidone; hypromellose - nesina met is indicated to improve glycaemic control in adult patients (> or = 18 years old) with type 2 diabetes mellitus when diet and exercise do not provide adequate glycaemic control and treatment with both alogliptin and metformin is appropriate,,- when treatment with metformin alone does not provide adequate control; or - in combination with a thiazolidinedione or with insulin, when dual therapy does not provide adequate control.,nesina met can also be used to replace separate tablets of alogliptin and metformin in patients already being treated with this combination.
cholurso 500 mg film-coated tablets
laboratoires mayoly spindler - ursodeoxycholic acid - film-coated tablet - 500 milligram(s) - bile acid preparations; ursodeoxycholic acid
clarithromycin 500 mg film-coated tablets
sun pharmaceutical industries europe b.v. - clarithromycin - film-coated tablet - 500 milligram(s) - macrolides; clarithromycin
clarithromycin 500 mg film-coated tablets
accord healthcare limited - clarithromycin - film-coated tablet - 500 milligram(s) - macrolides; clarithromycin
glucophage 500 mg film-coated tablets
merck serono (ireland) limited - metformin hydrochloride - film-coated tablet - 500 milligram(s) - biguanides; metformin
keflex 500 mg film-coated tablets
lexon (uk) ltd - cefalexin - film-coated tablet - 500 milligram(s) - first-generation cephalosporins; cefalexin
paracetamol rx 500 mg film-coated tablets
accord healthcare ireland ltd. - paracetamol - film-coated tablet - 500 milligram(s) - anilides; paracetamol
proursan 500 mg film-coated tablets
pro.med.cs praha a.s. - ursodeoxycholic acid - film-coated tablet - 500 milligram(s) - bile acid preparations; ursodeoxycholic acid